MedMira Historical Cash Flow

MIR Stock

CAD 0.12 0.01 7.69%

Analysis of MedMira cash flow over time is an excellent tool to project MedMira future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 143.1 K or Other Non Cash Items of 17.1 K as it is a great indicator of MedMira ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining MedMira latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether MedMira is a good buy for the upcoming year.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MedMira. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About MedMira Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in MedMira balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which MedMira's non-liquid assets can be easily converted into cash.

MedMira Cash Flow Chart

At this time, MedMira's Capital Expenditures is fairly stable compared to the past year. Total Cash From Financing Activities is likely to climb to about 5.4 M in 2025, whereas Free Cash Flow is likely to drop (4.4 M) in 2025.

Capital Expenditures Dividends Paid

Capital Expenditures

Capital Expenditures are funds used by MedMira to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of MedMira operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Most accounts from MedMira's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into MedMira current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MedMira. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

MedMira cash flow statement Correlations

	Change To Inventory	Free Cash Flow	Change In Working Capital	Depreciation	Other Non Cash Items	Capital Expenditures	Net Income	Change In Cash	End Period Cash Flow	Begin Period Cash Flow	Change To Account Receivables	Sale Purchase Of Stock	Dividends Paid	Net Borrowings	Change To Operating Activities	Change To Netincome	Change To Liabilities	Investments	Issuance Of Capital Stock
Change To Inventory		0.06	0.35	-0.43	0.03	-0.13	0.07	0.12	0.07	-0.13	0.12	0.63	-0.12	0.56	0.26	-0.28	0.25	-0.14	-0.02
Free Cash Flow	0.06		0.43	-0.49	0.54	-0.68	0.45	-0.56	-0.36	0.39	-0.58	0.06	0.57	-0.09	0.1	0.0	0.32	0.67	0.32
Change In Working Capital	0.35	0.43		-0.47	-0.03	-0.46	0.14	-0.23	-0.31	-0.09	0.24	0.34	0.26	0.43	0.22	-0.16	0.71	0.35	-0.15
Depreciation	-0.43	-0.49	-0.47		-0.14	0.51	0.17	0.38	0.25	-0.3	-0.04	-0.07	-0.13	0.02	0.2	-0.36	-0.34	-0.52	-0.18
Other Non Cash Items	0.03	0.54	-0.03	-0.14		-0.41	0.37	-0.36	-0.21	0.3	-0.63	0.08	0.29	-0.24	0.18	0.12	0.29	0.33	0.39
Capital Expenditures	-0.13	-0.68	-0.46	0.51	-0.41		-0.35	0.62	0.65	-0.04	0.04	0.03	-0.74	0.1	0.12	-0.31	-0.48	-0.91	-0.52
Net Income	0.07	0.45	0.14	0.17	0.37	-0.35		-0.22	-0.39	-0.22	-0.45	0.16	0.31	0.47	0.6	-0.5	0.42	0.29	0.35
Change In Cash	0.12	-0.56	-0.23	0.38	-0.36	0.62	-0.22		0.83	-0.55	0.15	-0.16	-0.63	0.32	0.2	-0.34	-0.26	-0.79	-0.45
End Period Cash Flow	0.07	-0.36	-0.31	0.25	-0.21	0.65	-0.39	0.83		-0.01	-0.08	-0.27	-0.55	0.04	0.03	-0.19	-0.41	-0.76	-0.47
Begin Period Cash Flow	-0.13	0.39	-0.09	-0.3	0.3	-0.04	-0.22	-0.55	-0.01		-0.38	-0.08	0.17	-0.52	-0.3	0.3	-0.18	0.22	0.06
Change To Account Receivables	0.12	-0.58	0.24	-0.04	-0.63	0.04	-0.45	0.15	-0.08	-0.38		0.03	-0.07	0.23	-0.24	0.18	0.08	-0.07	0.0
Sale Purchase Of Stock	0.63	0.06	0.34	-0.07	0.08	0.03	0.16	-0.16	-0.27	-0.08	0.03		0.0	0.39	0.38	-0.49	0.22	-0.15	-0.03
Dividends Paid	-0.12	0.57	0.26	-0.13	0.29	-0.74	0.31	-0.63	-0.55	0.17	-0.07	0.0		-0.21	-0.12	0.29	0.29	0.69	0.43
Net Borrowings	0.56	-0.09	0.43	0.02	-0.24	0.1	0.47	0.32	0.04	-0.52	0.23	0.39	-0.21		0.57	-0.58	0.44	-0.27	-0.09
Change To Operating Activities	0.26	0.1	0.22	0.2	0.18	0.12	0.6	0.2	0.03	-0.3	-0.24	0.38	-0.12	0.57		-0.73	0.15	-0.21	-0.06
Change To Netincome	-0.28	0.0	-0.16	-0.36	0.12	-0.31	-0.5	-0.34	-0.19	0.3	0.18	-0.49	0.29	-0.58	-0.73		-0.05	0.4	0.12
Change To Liabilities	0.25	0.32	0.71	-0.34	0.29	-0.48	0.42	-0.26	-0.41	-0.18	0.08	0.22	0.29	0.44	0.15	-0.05		0.36	0.12
Investments	-0.14	0.67	0.35	-0.52	0.33	-0.91	0.29	-0.79	-0.76	0.22	-0.07	-0.15	0.69	-0.27	-0.21	0.4	0.36		0.53
Issuance Of Capital Stock	-0.02	0.32	-0.15	-0.18	0.39	-0.52	0.35	-0.45	-0.47	0.06	0.0	-0.03	0.43	-0.09	-0.06	0.12	0.12	0.53

Click cells to compare fundamentals

MedMira Account Relationship Matchups

MedMira cash flow statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Change To Inventory	(13.2K)	33.8K	19.5K	4.4K	5.0K	4.8K
Free Cash Flow	(541.2K)	(2.0M)	(1.3M)	(3.7M)	(4.2M)	(4.4M)
Change In Working Capital	(36.6K)	(264.7K)	1.2M	27.2K	24.5K	23.2K
Other Cashflows From Financing Activities	1.3M	56.2K	525.2K	1.4M	1.3M	1.2M
Depreciation	207.8K	212.3K	212.9K	309.6K	278.6K	143.1K
Other Non Cash Items	1.1M	459.3K	(48.5K)	20K	18K	17.1K
Capital Expenditures	36.5K	69.7K	1.3K	742.5K	853.9K	896.6K
Total Cash From Operating Activities	(504.6K)	(1.9M)	(1.3M)	(2.9M)	(3.4M)	(3.5M)
Net Income	(675.8K)	(1.8M)	(2.7M)	(3.3M)	(3.8M)	(4.0M)
Total Cash From Financing Activities	139.3K	2.0M	1.2M	5.8M	5.2M	5.4M
Change In Cash	(401.9K)	33.5K	(20.3K)	2.1M	2.4M	2.5M
Change To Account Receivables	(1.0M)	560.0	(11.2K)	(70.6K)	(63.6K)	(66.8K)
Net Borrowings	1.0M	730.7K	(374.9K)	352.1K	404.9K	425.2K
Total Cashflows From Investing Activities	3.3K	(101.9K)	(36.5K)	(69.7K)	(62.7K)	(65.9K)
Change To Operating Activities	921.8K	758.5K	697.3K	391.8K	450.6K	345.0K
Change To Liabilities	127.1K	1.1M	322.1K	(571.9K)	(657.6K)	(624.8K)
Investments	(36.5K)	(69.7K)	(1.3K)	(742.5K)	(668.3K)	(634.9K)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for MedMira Stock Analysis

When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

MedMira Historical Cash Flow

About MedMira Cash Flow Analysis

MedMira Cash Flow Chart

Capital Expenditures

Dividends Paid

MedMira cash flow statement Correlations

MedMira Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MedMira cash flow statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for MedMira Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

End Period Cash Flow	+ 0.83	Change In Cash
Change To Liabilities	+ 0.71	Change In Working Capital
Investments	+ 0.69	Dividends Paid
Investments	+ 0.67	Free Cash Flow
End Period Cash Flow	+ 0.65	Capital Expenditures
Sale Purchase Of Stock	+ 0.63	Change To Inventory

Investments	- 0.91	Capital Expenditures
Investments	- 0.79	Change In Cash
Investments	- 0.76	End Period Cash Flow
Dividends Paid	- 0.74	Capital Expenditures
Change To Netincome	- 0.73	Change To Operating Activities
Capital Expenditures	- 0.68	Free Cash Flow